![Matt Gdovin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matt Gdovin active positions
Companies | Position | Start | End |
---|---|---|---|
Vitanova Biomedical, Inc.
![]() Vitanova Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitanova Biomedical, Inc. is a biotechnology company based in the United States that focuses on improving the lives of cancer patients and healthcare professionals. The private company is based in Kerrville, TX. The company aims to achieve this through the development and commercialization of their novel light-activated intracellular acidosis platform cancer therapy. Vitanova Biomedical is currently working on preclinical evidence to support progress towards regulatory clearance and market commercialization. The company was founded by Matt Gdovin and Greg Espenhover. Tom Roberts has been the CEO of the company since 2016. | Chief Tech/Sci/R&D Officer | 2016-03-31 | - |
Founder | - | - |
Career history of Matt Gdovin
Statistics
International
United States | 2 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Vitanova Biomedical, Inc.
![]() Vitanova Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitanova Biomedical, Inc. is a biotechnology company based in the United States that focuses on improving the lives of cancer patients and healthcare professionals. The private company is based in Kerrville, TX. The company aims to achieve this through the development and commercialization of their novel light-activated intracellular acidosis platform cancer therapy. Vitanova Biomedical is currently working on preclinical evidence to support progress towards regulatory clearance and market commercialization. The company was founded by Matt Gdovin and Greg Espenhover. Tom Roberts has been the CEO of the company since 2016. | Commercial Services |
- Stock Market
- Insiders
- Matt Gdovin
- Experience